Conference Date: 25 Nov 2008
Conference Ref: A11-4608
Venue: The Rembrandt Hotel, London
Key topics to be covered:
- Factors that affect adverse event reporting in premarketing clinical trials and postmarketing pharmacovigilance
- Importance of active query and clinical pharmacological principles in quality assessment of premarketing ICSRs
- Successful application of interventions designed to stimulate health professional reporting and foster higher quality reports in postmarketing pharmacovigilance to premarketing clinical trials
- How to craft effective case narratives
- Working with clinical investigators and clinical sites – lessons learned
- The relationship between quality integrated summaries of safety and quality risk management
- Recognize impact of the EU’s Volume 9A
- Understand postmarketing pharmacovigilance inspections in the US and EU
Please see PDF brochure above for further details or email sarah@management-forum.co.uk.